COLOMBO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 6.270
AS - Asia 4.433
EU - Europa 994
SA - Sud America 956
Continente sconosciuto - Info sul continente non disponibili 249
AF - Africa 103
OC - Oceania 5
Totale 13.010
Nazione #
US - Stati Uniti d'America 6.022
SG - Singapore 2.626
CN - Cina 861
BR - Brasile 775
VN - Vietnam 404
IT - Italia 267
IE - Irlanda 183
FI - Finlandia 157
HK - Hong Kong 119
CA - Canada 101
GB - Regno Unito 94
IN - India 83
DE - Germania 69
AR - Argentina 64
BD - Bangladesh 63
MX - Messico 59
FR - Francia 47
IQ - Iraq 32
TR - Turchia 31
PK - Pakistan 30
ZA - Sudafrica 28
CO - Colombia 27
RU - Federazione Russa 24
JP - Giappone 23
PL - Polonia 23
SE - Svezia 23
UA - Ucraina 23
EC - Ecuador 21
CR - Costa Rica 20
NL - Olanda 20
ID - Indonesia 19
VE - Venezuela 19
CL - Cile 17
MY - Malesia 16
PY - Paraguay 16
AE - Emirati Arabi Uniti 15
MA - Marocco 15
ES - Italia 13
KE - Kenya 13
UZ - Uzbekistan 13
PH - Filippine 11
JM - Giamaica 10
JO - Giordania 10
NG - Nigeria 10
GT - Guatemala 9
HN - Honduras 9
PR - Porto Rico 9
AL - Albania 8
TT - Trinidad e Tobago 8
TW - Taiwan 8
DO - Repubblica Dominicana 7
DZ - Algeria 7
AZ - Azerbaigian 6
OM - Oman 6
PE - Perù 6
RO - Romania 6
SA - Arabia Saudita 6
UY - Uruguay 6
CY - Cipro 5
ET - Etiopia 5
IL - Israele 5
KZ - Kazakistan 5
LT - Lituania 5
AT - Austria 4
AU - Australia 4
BO - Bolivia 4
GE - Georgia 4
NP - Nepal 4
PA - Panama 4
PS - Palestinian Territory 4
SV - El Salvador 4
TH - Thailandia 4
BE - Belgio 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
EE - Estonia 3
EG - Egitto 3
KG - Kirghizistan 3
LB - Libano 3
NI - Nicaragua 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AM - Armenia 2
AO - Angola 2
BN - Brunei Darussalam 2
BS - Bahamas 2
GH - Ghana 2
HU - Ungheria 2
KH - Cambogia 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
UG - Uganda 2
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
Totale 12.741
Città #
Singapore 1.041
Ashburn 973
San Jose 970
The Dalles 453
Shanghai 366
Council Bluffs 291
New York 267
Dallas 238
Boardman 204
Dublin 183
Los Angeles 164
Helsinki 157
Beijing 156
Santa Clara 148
Ho Chi Minh City 133
Hanoi 116
Hong Kong 108
São Paulo 80
Milan 77
Buffalo 70
Phoenix 58
Rome 49
Seattle 46
Chandler 38
Atlanta 33
Chicago 31
Wilmington 31
Brooklyn 29
Montreal 27
Charlotte 26
Mexico City 25
Brasília 21
Warsaw 21
Boston 19
Chennai 19
Tokyo 19
Toronto 19
Johannesburg 18
London 18
Rio de Janeiro 18
Da Nang 17
Assago 16
Curitiba 16
Naples 16
Philadelphia 16
Pune 16
San José 16
Turin 16
North Bergen 14
Princeton 14
Queens 14
San Francisco 13
Baghdad 12
Miami 12
Nairobi 12
Columbus 11
Houston 11
Manchester 11
Orem 11
Pasadena 11
Porto Alegre 11
Amsterdam 10
Can Tho 10
Cleveland 10
Denver 10
Frankfurt am Main 10
Guarulhos 10
Haiphong 10
Quito 10
San Mateo 10
Ankara 9
Benin City 9
Milwaukee 9
Reston 9
Stockholm 9
Tampa 9
Tashkent 9
Abbeville 8
Buenos Aires 8
Dhaka 8
Hillsboro 8
Hải Dương 8
Indianapolis 8
Kuala Lumpur 8
Moscow 8
Recife 8
San Diego 8
Uberlândia 8
Belo Horizonte 7
Bến Tre 7
Campo Grande 7
Figino 7
Guangzhou 7
Guatemala City 7
Manaus 7
Pittsburgh 7
Sacramento 7
Santiago 7
Amman 6
Ann Arbor 6
Totale 7.369
Nome #
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 140
Clinical and Technical Challenges of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation 107
A Propensity Score Matched Comparative Study Between Paclitaxel-Coated Balloon and Everolimus-Eluting Stents for the Treatment of Small Coronary Vessels 103
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials 99
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 93
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 92
12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry 91
Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation 90
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 87
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 87
A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions 84
Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel 83
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 81
A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention 80
Acute and long-term (2-years) clinical outcomes of the CoreValve 31 mm in large aortic annuli: A multicenter study 80
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials 78
[Saphenous vein graft aneurysm: percutaneous exclusion using detachable coils] 78
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 77
The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock 75
Advances in percutaneous interventional therapies: The tricuspid valve 75
Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis 75
[Severe coronary artery disease and severely impaired renal function. Focused fluid expansion and ultra-low dose contrast medium administration] 73
Safety and efficacy of polymer-free drug-eluting stents: Amphilimus-eluting Cre8 versus biolimus-eluting biofreedom stents 73
Accuracy and reproducibility of aortic annular measurements obtained from echocardiographic 3D manual and semi-automated software analyses in patients referred for transcatheter aortic valve implantation: implication for prosthesis size selection 71
Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge mitraclip technique 70
The coronary sinus reducer: clinical evidence and technical aspects 70
Endovascular treatment of a noninfected anastomotic juxtarenal aortic aneurysm 69
Unprotected left main revascularization: Percutaneous coronary intervention versus coronary artery bypass. An updated systematic review and meta-analysis of randomised controlled trials 68
Anatomic and procedural associations of transcatheter heart valve displacement following Evolut R implantation 68
6 Months’ Follow-Up of the First-in-Man Implantation of a Novel Tricuspid Flow Optimizer 68
Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention Through Ipsilateral Collateral Channels: A Multicenter Registry 68
Hypertrophic Left Ventricle With Small Cavity and Severe Aortic Angulation: A Dangerous Association in Case of Transcatheter Aortic Valve Replacement 67
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 67
A Novel Technique for Prosthetic Valve Retrieval After Transcatheter Aortic Valve Embolization 67
Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli The TAVI-SMALL Registry 67
Single-Antiplatelet Therapy in Patients with Contraindication to Dual-Antiplatelet Therapy After Transcatheter Aortic Valve Implantation 67
A Case of Very Late (3 Years) Transcatheter Heart Valve Thrombosis 67
Key Imaging Factors for Transcatheter Management of Tricuspid Regurgitation: Device and Patient Selection 66
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry) 66
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry 66
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 65
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 65
Transradial versus transfemoral ancillary approach in complex structural, coronary, and peripheral interventions. Results from the multicenter ancillary registry: A study of the Italian Radial Club 65
A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation 65
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease 64
Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: Early results of the feasibility trial 63
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 63
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 63
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 63
Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience 63
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 63
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry 63
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 62
Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches 62
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis 62
A Fully Percutaneous Transeptal Transcatheter Mitral Valve Replacement With a Novel Device 62
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 62
Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System 62
Clinical Outcomes With a Repositionable Self-Expanding Transcatheter Aortic Valve Prosthesis: The International FORWARD Study 61
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 61
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry 60
Repeat MitraClip for early recurrent mitral regurgitation 60
The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris 59
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 59
Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access: A Multicenter Prospective Study 59
Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry 59
State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey 59
Mechanism and Implications of the Tricuspid Regurgitation: From the Pathophysiology to the Current and Future Therapeutic Options 59
Outcomes of the retrograde approach through epicardial versus non-epicardial collaterals in chronic total occlusion percutaneous coronary intervention 59
Prognostic value of tricuspid regurgitation 59
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease 59
Procedural and Long-Term Outcomes of Percutaneous Coronary Intervention for In-Stent Chronic Total Occlusion 59
Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison 59
Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis 59
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 58
Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients 58
Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 58
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion 58
Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom 58
New generation bioresorbable scaffold technologies: An update on novel devices and clinical results 58
Which is the best anti-aggregant or anti-coagulant therapy after TAVI? A propensity matched analysis from the ITER registry. The management of DAPT after TAVI 58
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock 57
Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention 57
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 57
Multimodality Imaging of a Very Late Thrombosis of a Sutureless Aortic Prosthesis 57
Long-term outcomes of rotational atherectomy for the percutaneous treatment of chronic total occlusions 56
Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions 56
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent 56
Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: Insight from the Italian CoreValve Registry 56
Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions 56
Prolonged Ultrasound-Assisted Catheter-Directed Low-Dose Thrombolysis for Acute Pulmonary Embolism Unresponsive to Systemic Thrombolysis 56
Current Risk of Contrast-Induced Acute Kidney Injury After Coronary Angiography and Intervention: A Reappraisal of the Literature 56
Contrast-induced kidney injury: how does it affect long-term cardiac mortality? 56
Feasibility of ultra-low contrast 64-slice computed tomography angiography before transcatheter aortic valve implantation: A real-world experience 56
How should i treat recurrent restenosis with underexpanded multilayered struts after repeated complex bifurcation stenting? 55
Percutaneous suture-based patent foramen ovale closure: A state-of-the-art review 55
White blood cell count and major adverse cardiovascular events after percutaneous coronary intervention in the contemporary era insights from the Paris study (Patterns of non-adherence to anti-platelet regimens in stented patients registry) 55
Anesthetic Management of Cardioband Implantation: Data From a Preliminary Experience and New Insights 55
Rotational atherectomy in the subadventitial space to allow safe and successful chronic total occlusion recanalization: Pushing the limit further 55
Clinical and procedural predictors of suboptimal outcome after treatment of drug-eluting stent restenosis in the unprotected distal left main stem. the Milan and New Tokyo (MITO) Registry 55
Totale 6.708
Categoria #
all - tutte 81.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.262


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202221 0 0 0 6 0 0 1 5 0 1 7 1
2022/2023401 9 4 8 24 22 11 2 10 48 38 207 18
2023/20241.675 106 80 386 139 128 312 77 73 25 55 133 161
2024/20252.310 70 5 7 37 53 305 159 129 464 620 253 208
2025/20266.254 913 411 275 499 214 314 1.867 226 343 421 272 499
2026/20272.310 264 398 1.266 382 0 0 0 0 0 0 0 0
Totale 13.010